BridgeBio Pharma Inc (NAS:BBIO)
$ 27.94 0.18 (0.65%) Market Cap: 5.23 Bil Enterprise Value: 6.44 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 48/100

BridgeBio Pharma Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 11:20AM GMT
Release Date Price: $11.11 (-10.11%)
Unidentified Analyst

Okay. Good morning, everyone. Thanks for joining us for the fireside chat for BridgeBio. I'm joined here by Neil Kumar, who is the CEO and Founder of the company.

Just before we get started, the disclosure -- for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.comresearchdisclosures. If you have any questions, please contact your Morgan Stanley sales representative. So why don't we get started?

Neil, maybe just for people that don't know the company as well, maybe give a few minute overview of the company, what you're up to, maybe the philosophy and maybe we'll start there?

Neil Kumar
BridgeBio Pharma, Inc. - Co-Founder, President, CEO & Director

Yes, sure. Well, first of all, thanks so much for the opportunity to present here and thanks to the entire Morgan Stanley team.

BridgeBio, for those of you that don't know, is a company that was founded about 6.5 years ago to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot